Publications by authors named "P De Quint"
Background: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an inflammatory disease affecting the peripheral nerves and the most frequent autoimmune polyneuropathy. Given the lack of established biomarkers or risk factors for the development of CIDP and patients' treatment response, this research effort seeks to identify potential clinical factors that may influence disease progression and overall treatment efficacy.
Methods: In this multicenter, retrospective analysis, we have screened 197 CIDP patients who presented to the University Hospitals in Düsseldorf, Berlin, Cologne, Essen, Magdeburg and Munich between 2018 and 2022.
Our aim was to determine the impact of antimicrobial stewardship tools (ASTs) and the COVID-19 pandemic on antibiotic consumption (AC). We used the national software Consores to determine AC in DDD/1000 days of hospitalization from 2017 to 2022 in voluntary private hospitals in France. The ASTs considered were: 1.
View Article and Find Full Text PDFArticle Synopsis
- Inflammatory neuromuscular disorders are immune-mediated diseases with varied symptoms and treatment responses, making it crucial to identify specific biomarkers for better understanding and management.
- This review focuses on biomarkers in conditions like Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, and idiopathic inflammatory myopathy, highlighting their diagnostic and prognostic roles and the need for more specific biomarkers.
- Although current biomarkers have potential to enhance disease management, challenges in their reliability and the rarity of these disorders underscore the necessity for further research and novel approaches in biomarker development.
Introduction: Apolipoprotein CII amyloidosis (AApoCII) is a rare form of amyloidosis. Here, we report a novel mutation associated with AApoCII amyloidosis in 5 patients and describe their clinical, renal biopsy, and mass spectrometry findings.
Methods: Five patients with renal AApoCII p.